Despite the fact that Wegovy is the FDA-approved semaglutide formulation specifically designed for obesity treatment, mainstream and social media platforms promoted off-label Ozempic use for cosmetic weight loss
However, the message to consumers is clear: before anything goes into your body, be skeptical of whats in it
However, theyre not cost-effective at their current net prices of approximately $6,200 and $8,400 per year, respectively (list prices are considerably higher)
Highlights of Prescribing Information for Ozempic
Long-term treatment is required
Its not clear if there is something unique about this class of drugs that leads to specific outcomes on the muscle, whether its a loss of mass or an improvement in muscle function and performance